For decades, the standard explanation for depression went something like this: your brain has too little serotonin, and antidepressants fix the imbalance. It was a tidy story, easy to explain to a patient in a fifteen-minute appointment, and it justified writing a prescription. It also was not a serious scientific consensus. It was a simplification that drug marketers loved and that researchers had largely retired from polite conversation by the 1990s.
If you have struggled with depression and felt let down on hearing this, that response is fair. The story was useful, even if it was wrong, and unwinding it without dismissing real suffering takes some care.
Where the story came from
The serotonin hypothesis emerged in the 1960s as a tentative inference from how early antidepressants worked. Researchers noticed that drugs which increased serotonin or norepinephrine sometimes lifted mood, and they reasoned backward to a possible deficiency. It was a hypothesis, not a finding. The technology to actually measure neurotransmitter levels in living human brains did not exist, and when proxies were eventually developed they failed to show the expected pattern.
By the time SSRIs reached the consumer market in the late 1980s and early 1990s, the original hypothesis had been substantially weakened in research circles. But it had also become an excellent advertising premise. Telling patients they had a chemical imbalance that medication could correct was concrete, destigmatizing, and persuasive. Pharmaceutical companies leaned in, and the simplification migrated into popular culture and clinical conversation as if it were settled science.
What the recent reviews actually say
A 2022 umbrella review in Molecular Psychiatry, led by Joanna Moncrieff, synthesized decades of research on serotonin and depression and found no consistent evidence supporting the imbalance model. The finding was not new to specialists, but it punctured the popular version of the story in a way that was hard to ignore. Coverage swung between two unhelpful extremes: that antidepressants do not work, or that the medical establishment had been lying.
Neither is quite right. SSRIs do appear to help some patients, especially with severe depression, and the effect is meaningful even if the mechanism is poorly understood. The honest position is that we have a class of drugs with modest, real effects through mechanisms we do not fully grasp, prescribed using a model that was always a metaphor at best. That is uncomfortable but not damning.
What this means for patients
If antidepressants help you, the new evidence does not change that. Subjective response is the most important data point in your own case, and stopping medication abruptly because of a headline can cause real harm. Talk with a clinician before changing anything.
What it should change is the framing. Depression is not a clean deficiency disease, and recovery often involves more than medication: therapy, sleep, exercise, social support, and sometimes time. Treating depression as a single-cause illness with a single-cause cure was always a marketing convenience.
The takeaway
The chemical imbalance line sold drugs and reduced stigma. It was not science. The drugs can still be useful, the suffering is still real, and a more honest story is finally taking hold. Professional support remains valuable, especially when navigating any change in treatment.
Leave a Reply